Yunkang Group Limited

HK$0.48As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2325Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 4Y CAGR (51.45%)
Div yield —
ROE 5.45%
Diagnostics & Research
Beta (5Y) (0.78)
PE TTM 4.009
TSR TTM (54.29%)
Mkt cap HK$281.0M
ROIC 48.15%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.613
27.76%
(20.53%)
Hold 1|2|12|2|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.01
0.01
23.01%
23.41%
27.53%
38.32%
Revenue¥M
18.88
19.76
19.87
20.65
11.41%
13.62%
16.14%
14.10%
Peers (US$35.84M)
Cap (US$)
PE
33.33M
—
Capital
TTM
5Y
10Y
Leveragex
0.689
2.457
2.401
EBIT/Intx
0.585
0.173
0.174
Own earn%
11.02
55.43
56.68
Sh yield%
24.42
33.49
31.98
Owners
Insiders/Inst%
14.20
73.32
Short interest%
3.20
SBC / revenue%
3.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
19–23
$1 testx
−13.0
Incr. ROIC%
6